Allison Barz Leahy, MD, MSc¹, Jennifer Brogdon, PhD², Lucy Cain, MBBS, FRACP³, Amanda M. Dinofia, MD, MSCE^1*, Joseph A. Fraietta, PhD^4*, Richard Hanna, MS^3*, Stephan Kadauke, MD, PhD³, Raabia Khan^3*, Yimei Li, PhD^1*, Shannon L. Maude, MD⁵, Regina M. Myers, MD¹, Laura Shinehouse^3*, Anna Sparrow, MSN, MPH, RN^3*, Melissa Varghese^3*, Lei Wang, PhD^3*, Yongping Wang, MD, PhD^6* and Stephan A. Grupp, MD, PhD⁷

¹Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA
²Novartis Institutes For Biomedical Research, Cambridge, MA
³Children's Hospital of Philadelphia, Philadelphia, PA
⁴Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
⁵The Children's Hospital of Philadelphia, Philadelphia, PA
⁶Children’s Hospital of Philadelphia, Philadelphia, PA
⁷Children’s Hospital of Philadelphia and Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA

Bernhard Lehnertz, PhD^1*, Maéva Langouët, PhD^1*, Susan Moore, PhD^2*, Nadine Mayotte, MS^3*, Tara Macrae^4*, Etienne Gagnon, PhD^5* and Guy Sauvageau, MD/PhD^1,3

¹ExCellThera, Montreal, QC, Canada
²Université de Montréal, Montreal, QC, Canada
³Institut de recherche en Immunologie et Cancer, Université de Montréal, Montreal, QC, Canada
⁴IRIC, Université de Montréal, Montreal, QC, CAN
⁵IRIC, Université de Montréal, Montreal, QC, Canada

Annabelle Minguy^1*, Jessica Trottier, MSc^1*, Jaime Leonel Sanchez-Dardon, MSc^1*, Cédric Mathieu, PhD^1*, Jean-Philippe Bastien, PhD^1*, Cédric Carli, PhD^1*, Claude Perreault, MD^2,3, Jean-Sebastien Delisle, MD, PhD^1,3, Vibhuti Dave, PhD^1,4* and Denis-Claude Roy, MD^1,3

¹Hematology-Oncology and Cell Therapy University Institute, Hôpital Maisonneuve-Rosemont Research Center, Montreal, QC, Canada
²Institut de recherche en immunologie et cancer (IRIC), Université de Montréal, Montréal, QC, Canada
³Department of Medicine, Université de Montréal, Montréal, QC, Canada
⁴Department of Microbiology, Infectiology and Immunology, Université de Montréal, Montréal, QC, Canada

Caitlin R. Hopkins^1*, Amanda M. DiNofia, MD, MSCE^2*, Shannon L. Maude, MD², Gregory M. Chen, MD, PhD^1*, Kwame Attah M. Boateng-Antwi, PhD^2*, Jessica Perazzelli^2*, Andres F. Mendez Corea^2*, Alexander Shestov, PhD^3*, Mercy Gohil^1*, Yimei Li, PhD^4*, Wei-Ting Hwang^5*, Bakir Valentić^1*, Shannon Christensen, PhD^6*, Julie Jadlowsky, PhD^1*, Regina M. Myers, MD, MSCE^2*, Caroline Diorio, MD², Megan M. Davis, PhD^6*, Theresa Colligon^1*, Gabriela Plesa^1*, Don L. Siegel, MD, PhD⁷, Bruce Levine, PhD^6,8, Carl H. June, MD^6,9, Roddy S. O'Connor, PhD^10*, Stephan A. Grupp, MD, PhD^2,11 and Joseph A. Fraietta, PhD^3,12*

¹Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA
²Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA
³Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
⁴Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA
⁵Department of Biostatistics, Epidemiology, and Informatics, The University of Pennsylvania Perelman School of Medicine, Philadelphia, PA
⁶Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA
⁷University of Pennsylvania, Philadelphia, PA
⁸Department of Pathology and Laboratory Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA
⁹Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA
¹⁰Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
¹¹Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia
¹²Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA

Bryan Hancock, PhD^1*, Jonatan Tuncel, PhD^1*, Kyla Omilusik, PhD^1*, Alison O'Connor, MS^1*, Bi-Huei Yang, PhD^1*, Matthew Haynes, MS^1*, Amanda Yzaguirre, PhD^1*, Karina Palomares^1*, Sandeep Kothapally Hanok^1*, Matthew Denholtz, PhD^1*, Martin Hosking, PhD^1*, Eigen Peralta, PhD^1*, Tom Lee, PhD^1*, Raedun Clarke, PhD^1*, Sjoukje Van Der Stegen, PhD^2*, John Goulding^1*, Jode Goodridge, PhD^1*, Michel Sadelain, MD PhD² and Bahram Valamehr, PhD¹

¹Fate Therapeutics, San Diego, CA
²Cell Therapy and Cell Engineering Facility, Memorial Sloan Kettering Cancer Center, New York, NY

Ping Li^1*, Jian Ge, PhD², Shiguang Ye^1*, Lili Zhou^1*, Yiming Gong, MD^3*, Huaying Ruan, MN^3*, Hosein Kouros-Mehr^3* and Aibin Liang, MD^1*

¹Department of Hematology, Tongji Hospital of Tongji University, Shanghai, China
²The First Affiliated Hospital, Hefei, China
³Shanghai First Song Therapeutics, Shanghai, China

Surbhi Sidana, MD¹, Christof Scheid^2*, Peter J. Mueller^3*, Petra Schuberth^3*, Hardik Modi^4*, Peter Krengel^4*, Romain Piault^3*, Xiaobo Zhong^4* and Paula Rodríguez-Otero, MD, PhD^5*

¹Stanford University School of Medicine, Stanford, CA
²University of Cologne, Cologne, Germany
³Bristol Myers Squibb, Boudry, Switzerland
⁴Bristol Myers Squibb, Princeton, NJ
⁵Clínica Universidad de Navarra, Pamplona, Spain

David B. Miklos, MD, PhD¹, Wike Tong, MS^2*, Eric Kim, BS^2*, Brandon Kerr, BS, MA^2*, Morgan Neuwirth, BS^2*, Laura Alquist, BSBM^2* and Clare Spooner, MBBS, BSc^2*

¹Stanford University, Stanford, CA
²Kite, a Gilead Company, Santa Monica, CA

Jose Antonio Bejarano Garcia^1*, Daniel Primo, PhD^2*, Maria Jose Palacios Barea^1*, Belén Sierro^1*, Beatriz Guijarro-Albaladejo^1*, Xian Weng, PhD^2*, Miranda Omenaca^2*, Estefania Garcia-Guerrero, PhD^1*, Joan Ballesteros, PhD^2* and Jose Antonio Pérez-Simón, MD, PhD¹

¹Instituto de Biomedicina de Sevilla (Consejo Superior de Investigaciones Científicas (CSIC), Universidad de Sevilla (US), Hospital Universitario Virgen del Rocío (HUVR))., Sevilla, Spain
²Vivia Biotech, Tres Cantos, Spain

Silin Sa, Ph.D.^1* and Liping Yu, PhD²

¹Applied Cells, Santa Clara, CA
²Applied Cells, Inc., Santa Clara, CA

Silvia Menegatti, PhD^1*, Sheila Lopez-Cobo, PhD^1*, Aurelien Sutra Del Galy^1*, Jaime Fuentealba, PhD^1*, Lisseth Silva^1*, Laeticia Perrin^1*, Sandrine Heurtebise-Chrétien^1*, Valentine Pottez-Jouatte, PhD^1,2*, Aurélie Darbois^1*, Nina Burgdorf^1*, Albane Simon^3*, Marguerite Laprie-Santenac, PharmD^3*, Michael Saitakis, PhD^4*, Bruce Wick, PhD^5,6,7*, Beau R Webber, PhD^5,6,7*, Branden S Moriarity, PhD^5,6,7*, Olivier Lantz, MD, PhD^1*, Sebastian Amigorena, PhD^1* and Laurie Menger, PhD^3*

¹Institut Curie, PSL University, INSERM U932, Immunity and Cancer, Paris, France
²CellAction (Cell therapy Acceleration and Innovation), Institut Curie, Suresnes, France
³Gustave Roussy, Paris-Saclay University, INSERM U1015, Villejuif, France
⁴Mnemo Therapeutics, Paris, France
⁵Department of Pediatrics, University of Minnesota, Minneapolis, MN
⁶Masonic Cancer Center, University of Minnesota, Minneapolis, MN
⁷Center for Genome Engineering, University of Minnesota, Minneapolis, MN

Jodi L Murakami^*, Claudia I Guevara^*, Qi Cai^*, Hsing-Chuan Tsai^*, Saikat Banerjee^*, Da Ming Ou^*, Sean C Yoder^*, Sophie Viaud^*, Quinn Walker^*, Sunanda Kumar^*, Beata Berent-Maoz^*, Gunce E Cinay^*, Emily Vincent^*, John L Langowski^* and David Barrett^*

Kite, a Gilead Company, Santa Monica, CA